The Hypermetabolic Response to Burn Injury and Interventions to Modify this Response

Clinics in Plastic Surgery

Volumn 36, Issue 4, 2009, Pages 583-596

  Williams, Felicia N ^a   Herndon, David N ^a,b   Jeschke, Marc G ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

blockade; Burns; Catabolism; Catecholamines; Hypermetabolism; Wasting

Indexed keywords

ACUTE PHASE PROTEIN; EXENDIN 4; FENOFIBRATE; HUMAN GROWTH HORMONE; INSULIN; KETOCONAZOLE; MUSCLE PROTEIN; OXANDROLONE; PROPRANOLOL; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACUTE PHASE RESPONSE; BRONCHOSPASM; BURN; BURN EXCISION; BURN PATIENT; CALORIC INTAKE; CATABOLISM; CATECHOLAMINE BLOOD LEVEL; CLINICAL TRIAL; CONTINUOUS INFUSION; CORTICOSTEROID BLOOD LEVEL; DRUG DOSE TITRATION; ENERGY EXPENDITURE; EXERCISE; GLUCOSE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HIRSUTISM; HORMONAL REGULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERMETABOLISM; HYPOGLYCEMIA; INSULIN RESISTANCE; LIVER DYSFUNCTION; MULTIPLE ORGAN FAILURE; MUSCLE ATROPHY; MUSCLE STRENGTH; NUTRITIONAL SUPPORT; PROTEIN DEGRADATION; PROTEIN INTAKE; QUALITY OF LIFE; REVIEW; SEPSIS; SHOCK; SKIN TRANSPLANTATION; SURVIVAL RATE; THERMOREGULATION;

BURNS; ENERGY METABOLISM; HUMANS; METABOLISM; MULTIPLE ORGAN FAILURE;

EID: 70349314619     PISSN: 00941298     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cps.2009.05.001     Document Type: Review

References (138)

1. Hart D.W., Wolf S.E., Mlcak R., et al. Persistence of muscle catabolism after severe burn. Surgery 128 2 (2000) 312-319
2. Reiss E., Pearson E., and Artz C.P. The metabolic response to burns. J Clin Invest 35 1 (1956) 62-77
3. Rutan R.L., and Herndon D.N. Growth delay in postburn pediatric patients. Arch Surg 125 3 (1990) 392-395
4. Wilmore D.W., Mason Jr. A.D., and Pruitt Jr. B.A. Insulin response to glucose in hypermetabolic burn patients. Ann Surg 183 3 (1976) 314-320
5. Yu Y.M., Tompkins R.G., Ryan C.M., et al. The metabolic basis of the increase of the increase in energy expenditure in severely burned patients. JPEN J Parenter Enteral Nutr 23 3 (1999) 160-168
6. Goldstein D.S., and Kopin I.J. Evolution of concepts of stress. Stress 10 2 (2007) 109-120
7. Selye H. Stress and the general adaptation syndrome. Br Med J 1 4667 (1950) 1383-1392
8. Selye H. An extra-adrenal action of adrenotropic hormone. Nature 168 4265 (1951) 149-150
9. Selye H., and Fortier C. Adaptive reaction to stress. Psychosom Med 12 3 (1950) 149-157
10. Wilmore D.W., Long J.M., Mason Jr. A.D., et al. Catecholamines: mediator of the hypermetabolic response to thermal injury. Ann Surg 180 4 (1974) 653-669
11. Jeschke M.G., Chinkes D.L., Finnerty C.C., et al. Pathophysiologic response to severe burn injury. Ann Surg 248 3 (2008) 387-401
12. Wilmore D.W., and Aulick L.H. Metabolic changes in burned patients. Surg Clin North Am 58 6 (1978) 1173-1187
13. Barrow R.E., Hawkins H.K., Aarsland A., et al. Identification of factors contributing to hepatomegaly in severely burned children. Shock 24 6 (2005) 523-528
14. Barrow R.E., Wolfe R.R., Dasu M.R., et al. The use of beta-adrenergic blockade in preventing trauma-induced hepatomegaly. Ann Surg 243 1 (2006) 115-120
15. Herndon D.N., Hart D.W., Wolf S.E., et al. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 345 17 (2001) 1223-1229
16. Wolfe R.R., Herndon D.N., Peters E.J., et al. Regulation of lipolysis in severely burned children. Ann Surg 206 2 (1987) 214-221
17. Jeschke M.G., Mlcak R.P., Finnerty C.C., et al. Burn size determines the inflammatory and hypermetabolic response. Crit Care 11 4 (2007) R90
18. Dickerson R.N., Gervasio J.M., Riley M.L., et al. Accuracy of predictive methods to estimate resting energy expenditure of thermally-injured patients. JPEN J Parenter Enteral Nutr 26 1 (2002) 17-29
19. Cuthbertson D.P., Angeles Valero Zanuy M.A., and Leon Sanz M.L. Post-shock metabolic response, 1942. Nutr Hosp 16 (2001) 176-182
20. Baron P.W., Barrow R.E., Pierre E.J., et al. Prolonged use of propranolol safely decreases cardiac work in burned children. J Burn Care Rehabil 18 3 (1997) 223-227
21. Herndon D.N., and Tompkins R.G. Support of the metabolic response to burn injury. Lancet 363 9424 (2004) 1895-1902
22. Bessey P.Q., Jiang Z.M., Johnson D.J., et al. Posttraumatic skeletal muscle proteolysis: the role of the hormonal environment. World J Surg 13 4 (1989) 465-471
23. Chang D.W., DeSanti L., and Demling R.H. Anticatabolic and anabolic strategies in critical illness: a review of current treatment modalities. Shock 10 3 (1998) 155-160
24. Newsome T.W., Mason Jr. A.D., and Pruitt Jr. B.A. Weight loss following thermal injury. Ann Surg 178 2 (1973) 215-217
25. Pereira C., Murphy K., Jeschke M., et al. Post burn muscle wasting and the effects of treatments. Int J Biochem Cell Biol 37 10 (2005) 1948-1961
26. Hart D.W., Wolf S.E., Chinkes D.L., et al. Determinants of skeletal muscle catabolism after severe burn. Ann Surg 232 4 (2000) 455-465
27. Jahoor F., Desai M., Herndon D.N., et al. Dynamics of the protein metabolic response to burn injury. Metabolism 37 4 (1988) 330-337
28. Kinney J.M., Long C.L., Gump F.E., et al. Tissue composition of weight loss in surgical patients. I. Elective operation. Ann Surg 168 3 (1968) 459-474
29. Wolfe R.R. Review: acute versus chronic response to burn injury. Circ Shock 8 1 (1981) 105-115
30. Carter E.A., Tompkins R.G., Babich J.W., et al. Thermal injury in rats alters glucose utilization by skin, wound, and small intestine, but not by skeletal muscle. Metabolism 45 9 (1996) 1161-1167
31. Wilmore D.W., Aulick L.H., Mason A.D., et al. Influence of the burn wound on local and systemic responses to injury. Ann Surg 186 4 (1977) 444-458
32. Greenhalgh D.G., Saffle J.R., Holmes J.H.T., et al. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res 28 6 (2007) 776-790
33. Murray C.K., Loo F.L., Hospenthal D.R., et al. Incidence of systemic fungal infection and related mortality following severe burns. Burns 34 8 (2008) 1108-1112
34. Pruitt Jr. B.A., McManus A.T., Kim S.H., et al. Burn wound infections: current status. World J Surg 22 2 (1998) 135-145
35. Goodall M., Stone C., and Haynes Jr. B.W. Urinary output of adrenaline and noradrenaline in severe thermal burns. Ann Surg 145 4 (1957) 479-487
36. Hart D.W., Wolf S.E., Chinkes D.L., et al. Effects of early excision and aggressive enteral feeding on hypermetabolism, catabolism, and sepsis after severe burn. J Trauma 54 4 (2003) 755-764
37. Thermoregulation. The American Heritage Dictionary. Available at: http://dictionary.reference.com/browse/thermoregulation. Accessed January 13, 2009.
38. Barr P.O., Birke G., and Liliedal S.O. [The treatment of thermal burns with dry, warm air]. Eksp Khir Anesteziol 13 2 (1968) 39-43 [in Russian]
39. Barr P.O., Birke G., Liljedahl S.O., et al. Studies on burns. X. Changes in BMR and evaporative water loss in the treatment of severe burns with warm dry air. Scand J Plast Reconstr Surg 3 1 (1969) 30-38
40. Caldwell F.T. Metabolic response to thermal trauma: II. Nutritional studies with rats at two environmental temperatures. Ann Surg 155 1 (1962) 119-126
41. Zawacki B.E., Spitzer K.W., Mason Jr. A.D., et al. Does increased evaporative water loss cause hypermetabolism in burned patients?. Ann Surg 171 2 (1970) 236-240
42. Wolfe R.R., Herndon D.N., Jahoor F., et al. Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med 317 7 (1987) 403-408
43. Lee J., and Herndon D.N. The pediatric burned patient. In: Herndon D.N. (Ed). Total burn care. 3rd edition (2007), Saunders Elsevier, Philadelphia 485-493
44. Wilmore D.W., Mason Jr. A.D., Johnson D.W., et al. Effect of ambient temperature on heat production and heat loss in burn patients. J Appl Phys 38 4 (1975) 593-597
45. Herndon D.N. Mediators of metabolism. J Trauma 21 (1981) 701-705
46. Dominioni L., Trocki O., Fang C.H., et al. Enteral feeding in burn hypermetabolism: nutritional and metabolic effects of different levels of calorie and protein intake. JPEN J Parenter Enteral Nutr 9 3 (1985) 269-279
47. Mochizuki H., Trocki O., Dominioni L., et al. Mechanism of prevention of postburn hypermetabolism and catabolism by early enteral feeding. Ann Surg 200 3 (1984) 297-310
48. Curreri P.W., Richmond D., Marvin J., et al. Dietary requirements of patients with major burns. J Am Diet Assoc 65 4 (1974) 415-417
49. Wilmore D.W., Curreri P.W., Spitzer K.W., et al. Supranormal dietary intake in thermally injured hypermetabolic patients. Surg Gynecol Obstet 132 5 (1971) 881-886
50. Hildreth M.A., Herndon D.N., Desai M.H., et al. Reassessing caloric requirements in pediatric burn patients. J Burn Care Rehabil 9 6 (1988) 616-618
51. Herndon D.N., Barrow R.E., Rutan R.L., et al. A comparison of conservative versus early excision: therapies in severely burned patients. Ann Surg 209 5 (1989) 547-553
52. Herndon D.N., Stein M.D., Rutan T.C., et al. Failure of TPN supplementation to improve liver function, immunity, and mortality in thermally injured patients. J Trauma 27 2 (1987) 195-204
53. Jeejeebhoy K.N. Total parenteral nutrition: potion or poison?. Am J Clin Nutr 74 2 (2001) 160-163
54. Hildreth M.A., Herndon D.N., Desai M.H., et al. Caloric needs of adolescent patients with burns. J Burn Care Rehabil 10 6 (1989) 523-526
55. Goran M.I., Peters E.J., Herndon D.N., et al. Total energy expenditure in burned children using the doubly labeled water technique. Am J Phys 259 4 Pt 1 (1990) E576-E585
56. Gore D.C., Rutan R.L., Hildreth M., et al. Comparison of resting energy expenditures and caloric intake in children with severe burns. J Burn Care Rehabil 11 5 (1990) 400-404
57. Hart D.W., Wolf S.E., Herndon D.N., et al. Energy expenditure and caloric balance after burn: increased feeding leads to fat rather than lean mass accretion. Ann Surg 235 1 (2002) 152-161
58. Askanazi J., Rosenbaum S.H., Hyman A.I., et al. Respiratory changes induced by the large glucose loads of total parenteral nutrition. J Am Med Assoc 243 14 (1980) 1444-1447
59. Klein C.J., Stanek G.S., and Wiles III C.E. Overfeeding macronutrients to critically ill adults: metabolic complications. J Am Diet Assoc 98 7 (1998) 795-806
60. Turina M., Fry D.E., and Polk Jr. H.C. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 33 7 (2005) 1624-1633
61. Wolfe R.R., Goodenough R.D., Burke J.F., et al. Response of protein and urea kinetics in burn patients to different levels of protein intake. Ann Surg 197 2 (1983) 163-171
62. Yu Y.M., Young V.R., Castillo L., et al. Plasma arginine and leucine kinetics and urea production rates in burn patients. Metabolism 44 5 (1995) 659-666
63. Hoerr R.A., Matthews D.E., Bier D.M., et al. Effects of protein restriction and acute refeeding on leucine and lysine kinetics in young men. Am J Phys 264 4 Pt 1 (1993) E567-E575
64. Melville S., McNurlan M.A., McHardy K.C., et al. The role of degradation in the acute control of protein balance in adult man: failure of feeding to stimulate protein synthesis as assessed by L-[1-13C]leucin infusion. Metabolism 38 3 (1989) 248-255
65. Yu Y.M., Ryan C.M., Burke J.F., et al. Relations among arginine, citrulline, ornithine, and leucine kinetics in adult burn patients. Am J Clin Nutr 62 5 (1995) 960-968
66. Matthews D.E., Marano M.A., and Campbell R.G. Splanchnic bed utilization of leucine and phenylalanine in humans. Am J Phys 264 1 Pt 1 (1993) E109-E118
67. Norbury W.B., and Herndon D.N. Modulation of the hypermetabolic response after burn injury. In: Herndon D.N. (Ed). Total burn care. 3rd edition (2007), Saunders Elsevier, Philadelphia 420-433
68. Saffle J.R., and Graves C. Nutritional support of the burned patient. In: Herndon D.N. (Ed). Total burn care. 3rd edition (2007), Saunders Elsevier, Philadelphia 398-419
69. Patterson B.W., Nguyen T., Pierre E., et al. Urea and protein metabolism in burned children: effect of dietary protein intake. Metabolism 46 5 (1997) 573-578
70. Hart D.W., Wolf S.E., Zhang X.J., et al. Efficacy of a high-carbohydrate diet in catabolic illness. Crit Care Med 29 7 (2001) 1318-1324
71. Ferrando A.A., Lane H.W., Stuart C.A., et al. Prolonged bed rest decreases skeletal muscle and whole body protein synthesis. Am J Phys 270 4 Pt 1 (1996) E627-E633
72. Celis M.M., Suman O.E., Huang T.T., et al. Effect of a supervised exercise and physiotherapy program on surgical interventions in children with thermal injury. J Burn Care Rehabil 24 1 (2003) 57-61 [discussion: 56]
73. Cucuzzo N.A., Ferrando A., and Herndon D.N. The effects of exercise programming vs traditional outpatient therapy in the rehabilitation of severely burned children. J Burn Care Rehabil 22 3 (2001) 214-220
74. Neugebauer C.T., Serghiou M., Herndon D.N., et al. Effects of a 12-week rehabilitation program with music & exercise groups on range of motion in young children with severe burns. J Burn Care Res 29 6 (2008) 939-948
75. Suman O.E., Spies R.J., Celis M.M., et al. Effects of a 12-wk resistance exercise program on skeletal muscle strength in children with burn injuries. J Appl Phys 91 3 (2001) 1168-1175
76. Heszele M.F., and Price S.R. Insulin-like growth factor I: the yin and yang of muscle atrophy. Endocrinology 145 11 (2004) 4803-4805
77. Herndon D.N., Hawkins H.K., Nguyen T.T., et al. Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg 221 6 (1995) 649-659
78. Klein G.L., Wolf S.E., Langman C.B., et al. Effects of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury. J Clin Endocrinol Metab 83 1 (1998) 21-24
79. Herndon D.N. Nutritional and pharmacological support of the metabolic response to injury. Minerva Anestesiol 69 4 (2003) 264-274
80. Herndon D.N., Barrow R.E., Kunkel K.R., et al. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 212 4 (1990) 424-431
81. Barret J.P., Dziewulski P., Jeschke M.G., et al. Effects of recombinant human growth hormone on the development of burn scarring. Plast Reconstr Surg 104 3 (1999) 726-729
82. Jeschke M.G., Herndon D.N., Wolf S.E., et al. Recombinant human growth hormone alters acute phase reactant proteins, cytokine expression, and liver morphology in burned rats. J Surg Res 83 2 (1999) 122-129
83. Jeschke M.G., Chrysopoulo M.T., Herndon D.N., et al. Increased expression of insulin-like growth factor-I in serum and liver after recombinant human growth hormone administration in thermally injured rats. J Surg Res 85 1 (1999) 171-177
84. Jeschke M.G., Barrow R.E., and Herndon D.N. Recombinant human growth hormone treatment in pediatric burn patients and its role during the hepatic acute phase response. Crit Care Med 28 5 (2000) 1578-1584
85. Ramirez R.J., Wolf S.E., Barrow R.E., et al. Growth hormone treatment in pediatric burns: a safe therapeutic approach. Ann Surg 228 4 (1998) 439-448
86. Takagi K., Suzuki F., Barrow R.E., et al. Recombinant human growth hormone modulates Th1 and Th2 cytokine response in burned mice. Ann Surg 228 1 (1998) 106-111
87. Takagi K., Suzuki F., Barrow R.E., et al. Growth hormone improves immune function and survival in burned mice infected with herpes simplex virus type 1. J Surg Res 69 1 (1997) 166-170
88. Hart D.W., Herndon D.N., Klein G., et al. Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy. Ann Surg 233 6 (2001) 827-834
89. Mlcak R.P., Suman O.E., Murphy K., et al. Effects of growth hormone on anthropometric measurements and cardiac function in children with thermal injury. Burns 31 1 (2005) 60-66
90. Aili Low J.F., Barrow R.E., Mittendorfer B., et al. The effect of short-term growth hormone treatment on growth and energy expenditure in burned children. Burns 27 5 (2001) 447-452
91. Low J.F., Herndon D.N., and Barrow R.E. Effect of growth hormone on growth delay in burned children: a 3-year follow-up study. Lancet 354 9192 (1999) 1789
92. Singh K.P., Prasad R., Chari P.S., et al. Effect of growth hormone therapy in burn patients on conservative treatment. Burns 24 8 (1998) 733-738
93. Takala J., Ruokonen E., Webster N.R., et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341 11 (1999) 785-792
94. Cioffi W.G., Gore D.C., Rue III L.W., et al. Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury. Ann Surg 220 3 (1994) 310-319
95. Herndon D.N., Ramzy P.I., DebRoy M.A., et al. Muscle protein catabolism after severe burn: effects of IGF-1/IGFBP-3 treatment. Ann Surg 229 5 (1999) 713-722
96. Moller S., Jensen M., Svensson P., et al. Insulin-like growth factor 1 (IGF-1) in burn patients. Burns 17 4 (1991) 279-281
97. Jeschke M.G., Herndon D.N., and Barrow R.E. Insulin-like growth factor I in combination with insulin-like growth factor binding protein 3 affects the hepatic acute phase response and hepatic morphology in thermally injured rats. Ann Surg 231 3 (2000) 408-416
98. Spies M., Wolf S.E., Barrow R.E., et al. Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children. Crit Care Med 30 1 (2002) 83-88
99. Ferrando A.A., Sheffield-Moore M., Wolf S.E., et al. Testosterone administration in severe burns ameliorates muscle catabolism. Crit Care Med 29 10 (2001) 1936-1942
100. Lephart E.D., Baxter C.R., and Parker Jr. C.R. Effect of burn trauma on adrenal and testicular steroid hormone production. J Clin Endocrinol Metab 64 4 (1987) 842-848
101. Woolf P.D. Hormonal responses to trauma. Crit Care Med 20 2 (1992) 216-226
102. Ferrando A.A., Tipton K.D., Doyle D., et al. Testosterone injection stimulates net protein synthesis but not tissue amino acid transport. Am J Phys 275 5 Pt 1 (1998) E864-E871
103. Sheffield-Moore M., Urban R.J., Wolf S.E., et al. Short-term oxandrolone administration stimulates net muscle protein synthesis in young men. J Clin Endocrinol Metab 84 8 (1999) 2705-2711
104. Hart D.W., Wolf S.E., Ramzy P.I., et al. Anabolic effects of oxandrolone after severe burn. Ann Surg 233 4 (2001) 556-564
105. Jeschke M.G., Finnerty C.C., Suman O.E., et al. The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann Surg 246 3 (2007) 351-362
106. Barrow R.E., Dasu M.R., Ferrando A.A., et al. Gene expression patterns in skeletal muscle of thermally injured children treated with oxandrolone. Ann Surg 237 3 (2003) 422-428
107. Demling R.H., and DeSanti L. Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns. J Trauma 43 1 (1997) 47-51
108. Przkora R., Jeschke M.G., Barrow R.E., et al. Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment. Ann Surg 242 3 (2005) 384-391
109. Gore D.C., Chinkes D., Heggers J., et al. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 51 3 (2001) 540-544
110. Gore D.C., Chinkes D.L., Hart D.W., et al. Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med 30 11 (2002) 2438-2442
111. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 19 (2001) 1359-1367
112. Aarsland A., Chinkes D.L., Sakurai Y., et al. Insulin therapy in burn patients does not contribute to hepatic triglyceride production. J Clin Invest 101 10 (1998) 2233-2239
113. Sakurai Y., Aarsland A., Herndon D.N., et al. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg 222 3 (1995) 283-294 294-7
114. Pierre E.J., Barrow R.E., Hawkins H.K., et al. Effects of insulin on wound healing. J Trauma 44 2 (1998) 342-345
115. Thomas S.J., Morimoto K., Herndon D.N., et al. The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery 132 2 (2002) 341-347
116. Cree M.G., Zwetsloot J.J., Herndon D.N., et al. Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate. Ann Surg 245 2 (2007) 214-221
117. Minnich A., Tian N., Byan L., et al. A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle. Am J Physiol Endocrinol Metab 280 2 (2001) E270-E279
118. Schnabel C.A., Wintle M., and Kolterman O. Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes. Vasc Health Risk Manag 2 1 (2006) 69-77
119. Nelson P., Poon T., Guan X., et al. The incretin mimetic exenatide as a monotherapy in patients with type 2 diabetes. Diabetes Technol Ther 9 4 (2007) 317-326
120. Breitenstein E., Chiolero R.L., Jequier E., et al. Effects of beta-blockade on energy metabolism following burns. Burns 16 4 (1990) 259-264
121. Herndon D.N., Barrow R.E., Rutan T.C., et al. Effect of propranolol administration on hemodynamic and metabolic responses of burned pediatric patients. Ann Surg 208 4 (1988) 484-492
122. Minifee P.K., Barrow R.E., Abston S., et al. Improved myocardial oxygen utilization following propranolol infusion in adolescents with postburn hypermetabolism. J Pediatr Surg 24 8 (1989) 806-811
123. Mangano D.T., Layug E.L., Wallace A., et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335 23 (1996) 1713-1720
124. Herndon D.N., Nguyen T.T., Wolfe R.R., et al. Lipolysis in burned patients is stimulated by the beta 2-receptor for catecholamines. Arch Surg 129 12 (1994) 1301-1305
125. Aarsland A., Chinkes D., Wolfe R.R., et al. Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone: rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged. Ann Surg 223 6 (1996) 777-789
126. Barret J.P., Jeschke M.G., and Herndon D.N. Fatty infiltration of the liver in severely burned pediatric patients: autopsy findings and clinical implications. J Trauma 51 4 (2001) 736-739
127. Gore D.C., Honeycutt D., Jahoor F., et al. Propranolol diminishes extremity blood flow in burned patients. Ann Surg 213 6 (1991) 568-574
128. Morio B., Irtun O., Herndon D.N., et al. Propranolol decreases splanchnic triacylglycerol storage in burn patients receiving a high-carbohydrate diet. Ann Surg 236 2 (2002) 218-225
129. Vaughan G.M., Becker R.A., Allen J.P., et al. Cortisol and corticotrophin in burned patients. J Trauma 22 4 (1982) 263-273
130. Wise L., Margraf H.W., and Ballinger W.F. Adrenal cortical function in severe burns. Arch Surg 105 2 (1972) 213-220
131. Lyman C.A., and Walsh T.J. Systemically administered antifungal agents: a review of their clinical pharmacology and therapeutic applications. Drugs 44 1 (1992) 9-35
132. Engelhardt D., Dorr G., Jaspers C., et al. Ketoconazole blocks cortisol secretion in man by inhibition of adrenal 11 beta-hydroxylase. Klin Wochenschr 63 13 (1985) 607-612
133. Engelhardt D., Mann K., Hormann R., et al. Ketoconazole inhibits cortisol secretion of an adrenal adenoma in vivo and in vitro. Klin Wochenschr 61 7 (1983) 373-375
134. Loose D.S., Stover E.P., and Feldman D. Ketoconazole binds to glucocorticoid receptors and exhibits glucocorticoid antagonist activity in cultured cells. J Clin Invest 72 1 (1983) 404-408
135. Hart D.W., Wolf S.E., Chinkes D.L., et al. Beta-blockade and growth hormone after burn. Ann Surg 236 4 (2002) 450-457
136. Jeschke M.G., Finnerty C.C., Kulp G.A., et al. Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children. Pediatr Crit Care Med 9 2 (2008) 209-216
137. Debroy M.A., Wolf S.E., Zhang X.J., et al. Anabolic effects of insulin-like growth factor in combination with insulin-like growth factor binding protein-3 in severely burned adults. J Trauma 47 5 (1999) 904-911
138. Ferrando A.A., Chinkes D.L., Wolf S.E., et al. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg 229 1 (1999) 11-18